What is Pulsenmore Ltd. Ordinary Shares?
engages in the provision of self-scan ultrasound devices for remote clinical diagnosis and screening in Israel and Europe.
PLSM · Verdict
Moderate reward · moderate risk
PLSM stands out on volatility and growth, but watch the profitability signal.
Based on 88% data coverage
PLSM · Verdict
Top decile vs peers
Rev +73.5% CAGR · earnings +6.9%
Above average
-380% net margin · -46% ROE
-355% free-cash-flow margin
Model-based scoring. For information only — not financial advice.
engages in the provision of self-scan ultrasound devices for remote clinical diagnosis and screening in Israel and Europe. The company offers Pulsenmore home ultrasound system, a handheld ultrasound cradle dock with the patient's smartphone; mobile app for uploading images to the cloud for review; and clinician dashboard for clinician to review a stored video or guide a scan in real-time. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 28.81M.
The scoring profile indicates limited reward potential at this time, with growth and valuation offering the most support. Risk indicators are moderate, consistent with typical market exposure.
For informational purposes only. Not financial advice.